Lotronex alosetron selective 5-HT3 antagonist regulatory update

The FDA granted marketing approval for Lotronex to treat women with irritable bowel syndrome (IBS) with symptoms of abdominal pain and discomfort and diarrhea. Product launch is expected mid-March. ...